WHO Global Benchmarking Tool is a “Game-changer” for Regulatory Systems Strengthening

This blog is part of the blog series “Pharmaceutical Systems in Practice: Global Insights” and was originally posted on the USAID MTaPS Program website. According to the World Health Organization (WHO), an estimated 1 en 10 pharmaceutical products sold globally is falsified or substandard,¹ with deadly effects and the situation is known to be far [more…]

Girls with Disabilities, on Periods.

By Dr.Shubha Nagesh, an Atlantic Fellow for Global Health Equity, and Muskaan Vohra, student at Monash University. The World Economic Forum (WEF) highlights three main barriers preventing girls and women from accessing proper menstrual hygiene, including lack of awareness, acceptance, and access to hygiene products. Menstruation is natural, but the onset of menarche may pose [more…]

Thinking about gender while responding to an epidemic: Must have or nice to have?

Mars 2020 is unique in that it is both Women’s History Month and the month when WHO declared the novel coronavirus disease (COVID-19) a pandemic. Lessons learned from previous disease outbreaks of other coronaviruses (MERS and SARS), Ebola, and Zika, have highlighted the lack of gender considerations in epidemic preparedness and responses, and its consequences. [more…]